We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Medtronic Neuro Gets Warning Letter, FDA Wants to Meet on Motor Flaws
Medtronic Neuro Gets Warning Letter, FDA Wants to Meet on Motor Flaws
August 31, 2012
Medtronic’s neuromodulation unit has received an FDA warning letter on allegations the business segment did not handle complaints properly, among other corrective and preventive action (CAPA) violations.